Most Americans are focused on what they’re being charged for health care, not how much they or an aging population are consuming, according to a new POLITICO/Harvard T.H. Chan School…
Month: March 2019
Do we have the courage to address healthcare?
KEY TAKEAWAY: Our current healthcare model i not sustainable. To change healthcare is going to require an approach that removes lobbyist money and focuses on delivering a healthcare experience that…
Pharma tightening the noose around their own necks
IN SUMMARY: Novartis will price its new Mayzent multiple sclerosis drug at 88,000 dollars per year which is more proof that pharma companies could care less about the heated debate…
Some healthcare facts we all should know
In a partisan political climate, leaders on both sides of the aisle have identified an urgent challenge: the price of prescription drugs. The average American pays approximately $1,200 a year for prescriptions – and that…
The craziness of pharma drug pricing
Lilly says the net price for its Humalog insulin—the price after discounts and rebates—fell to an average of $135 a patient a month in 2018, from $147 in 2014. During…
The correlation between Theranos and digital health
IN SUMMARY: According to the HBO documentary on Theranos “there’s a lot of lying in Silicon Valley.” The lying is still going on when it comes to digital and mhealth,…
Biogen dupes us all
KEY TAKEAWAY: “We still believe that amyloid beta hypothesis is potentially the right approach for the treatment of Alzheimer’s disease,” an Eisai spokesman told Reuters. What made Wall Street and everyone…
Biogen’s fall: the key lessons
KEY TAKEAWAY: Biotech companies that transform themselves into big pharma on the strength of one or two drugs are destined to fail if they forget what made them great. Biogen…